The Global Haemophilia Market Size Was Valued at USD 13.00 Billion in 2023 and is Projected to Reach USD 18.91 Billion by 2032, Growing at a CAGR of 4.25% From 2024-2032.
Haemophilia is a rare genetic bleeding disorder characterized by the deficiency or absence of specific clotting factors, primarily Factor VIII (Haemophilia A) or Factor IX (Haemophilia B). This condition prevents the blood...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek